SUNPHARMA IN EQUITY
loading…—
Day range—
52-week range—
Market cap—
P/E · TTM—
As of—
| ₹ CR · FY | FY22 | FY23 | FY24 | FY25 | FY26 | Sep'26 | YOY |
|---|---|---|---|---|---|---|---|
| Profit & loss | |||||||
| Revenue | 38,654 | 43,886 | 48,497 | 52,578 | 58,462 | — | — |
| Operating profit | 10,258 | 11,650 | 13,018 | 15,114 | 16,501 | — | — |
| OPM % | 26.5% | 26.5% | 26.8% | 28.7% | 28.2% | — | |
| Interest | 127 | 172 | 238 | 231 | 339 | — | — |
| Profit before tax | 4,481 | 9,408 | 11,088 | 13,752 | 15,119 | — | — |
| Net profit | 3,389 | 8,513 | 9,610 | 10,965 | 11,509 | — | — |
| NPM % | 8.8% | 19.4% | 19.8% | 20.9% | 19.7% | — | |
| Balance sheet & cash | |||||||
| Total assets | 69,776 | 80,712 | 85,328 | 91,908 | 1,08,407 | 1,14,838 | +5.9% |
| Equity | 48,011 | 55,995 | 63,667 | 72,218 | 83,570 | 89,280 | +6.8% |
| Debt | 1,290 | 6,886 | 3,274 | 2,362 | 4,627 | 3,241 | −30% |
| Cash from ops | 8,985 | 4,959 | 12,135 | 14,072 | 12,419 | — | — |
| Capex | — | — | — | — | — | — | — |
| CHECK | RESULT | VALUE |
|---|---|---|
| Net profit positive | n/a | — |
| Operating cash flow positive | n/a | — |
| ROA improved | n/a | 10.6% → — |
| Cash from ops > net profit | n/a | — |
| Leverage fell | ✓ PASS | 0.04 → 0.03 |
| Current ratio improved | n/a | — → — |
| Gross margin improved | n/a | 28.2% → — |
| Asset turnover improved | n/a | 0.54 → — |
| Interest cover above 3× | n/a | — |
| ₹ CR · QUARTER | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | YOY |
|---|---|---|---|---|---|---|---|---|---|
| Profit & loss | |||||||||
| Revenue | 13,675 | 12,959 | 13,851 | 14,478 | 15,521 | 14,612 | 15,300 | 16,199 | +11.9% |
| Operating profit | 4,009 | 3,716 | 4,302 | 4,527 | 4,948 | 3,954 | 4,418 | 4,744 | +4.8% |
| OPM % | 29.3% | 28.7% | 31.1% | 31.3% | 31.9% | 27.1% | 28.9% | 29.3% | |
| Interest | 52 | 49 | 75 | 100 | 78 | 86 | 100 | 75 | −25% |
| Profit before tax | 3,476 | 3,254 | 3,173 | 4,168 | 4,227 | 3,551 | 4,099 | 3,159 | −24.2% |
| Net profit | 2,913 | 2,154 | 2,293 | 3,125 | 3,381 | 2,710 | 2,901 | 1,995 | −36.2% |
| NPM % | 21.3% | 16.6% | 16.6% | 21.6% | 21.8% | 18.5% | 19.0% | 12.3% |